DUBLIN, Juun 26, 2023- Warbixinta "Suuqa Dawooyinka Peptide ee xaddidan - Falanqaynta Caalamiga ah iyo Gobolka: Diirada saar Noocyada Peptide, Alaabooyinka iyo Falanqaynta Gobolka - Falanqaynta iyo Saadaasha, 2024-2040".
Kadib suuqii ugu horeyay ee dawadii ugu horaysay ee peptide-ka la xadiday, suuqa dawooyinka xaddidan ee caalamiga ah ayaa la saadaalinayaa inuu kori doono 2024 ilaa 2040. Baaxadda suuqa ayaa la filayaa inuu gaadho $60M sanadka 2024 iyo $17.38B sanadka 2040, oo CAGR ah 38.94% in ka badan. xilliga saadaasha 2025-2040.
Suuqa dawooyinka peptide-ka xaddidan ee caalamiga ah ayaa la filayaa inuu la kulmo koboc aad u weyn inta lagu jiro xilliga saadaasha laga bilaabo 2025 illaa 2040, taasoo qayb weyn ka ah ballanqaadka horumar cusub oo xaddidaya dhuumaha peptide-ka oo aan hadda ku xaddidnayn bartilmaameedyada soo-dhoweynta.Horumarka tignoolajiyada kiimikada, horumarka laga gaaray suuqgeynta daweynta peptide synthetic sanadihii ugu dambeeyay, iyo qiimayaasha la awoodi karo ee ay heleen biomolecules-ka cudurada kala duwan ayaa ah arrimo dheeri ah oo gacan ka geysanaya koritaanka la saadaaliyay ee xilliga saadaasha.
Falanqaynta saameynta mustaqbalka dhow iyo kuwa fog waxaa lagu fuliyaa arrimo si weyn u saameeya suuqa, kuwaas oo ah darawallada, caqabadaha iyo fursadaha.Qiimaynta muddada-gaaban waxay tixgalinaysaa muddada 2020-2025 iyo qiimaynta muddada-dheer waxay tixgelisaa muddada 2026-2040.
Horumarrada muhiimka ah iyo xeeladaha ay qaateen qaar ka mid ah ciyaartoyga muhiimka ah ee suuqan ayaa lagu daray qiimaynta falanqaynta saamaynta.Intaa waxaa dheer, horumarintan muhiimka ah waxaa lagu qiimeeyaa si loo fahmo fursadaha mustaqbalka ee isku-dhafka tignoolajiyada horumarsan si loo gaaro natiijooyin sare.Intaa waxaa dheer, ansixinta iyo bilaabista shirkadaha iyo wakaaladaha patent-ka ayaa sidoo kale lagu xisaabtamayaa marka la qiimeynayo dhaqdhaqaaqa suuqa caalamiga ah ee dawooyinka peptide-xaddidan.
Qodobbada Baahida iyo Caqabadaha Kuwan soo socda ayaa ah qodobbada baahida suuqa ka-hortagga ku-tiirsanaanta Peptide ee caalamiga ah:
4 Dulmarka Suuqa 4.1 Hordhac 4.1.1 Qaab dhismeedka iyo Nakhshadeynta Peptides xaddidan 4.1.2 Noocyada Peptides xaddidan 4.2 Kobcinta Peptides xaddidan 4.3 Horumarinta Peptides xaddidan sida daawooyinka 4.7 Isbeddellada warshadaha muhiimka ah ee jidka hordhaca ah 4.8 Isbeddellada warshadaha muhiimka ah - horumarka tignoolajiyada 4.9 baaxadda suuqa ee hadda iyo awoodda kobaca, USD bilyan, 2024-2040 iyo cusbooneysiinta shirkadaha soo saara dawooyinka peptide-ka xaddidan.
5. Guryaha peptides-ka qaabaysan u xaddidan yahay daahfurka (5.2.5 dareeraha-wejiga Peptide Synthesis (LPPS) 5.2.6 Dooro Nidaamka
6.1 xogta warshadaha qaanuunka 6.5 Shuruudaha sharciga Yurub iyo qaabka 6.5.1 Habka codsiga shatiga EMA 6.5.2 Nidaamyada dhexdhexaadinta 6.5.3 Nidaamyada dhexdhexaadinta 6.5.4 Nidaamyada aqoonsiga labada dhinac1 Shuruudaha sharciga ah iyo qaab-dhismeedka Japan 6.7 Xaaladaha lacag-celinta
7 Dhaqdhaqaaqa Suuqa 7.1 Falanqaynta Saamaynta 7.2 Qodobbada Suuqa 7.2.1 Kordhinta Xidhiidhka Isku Xidhka iyo Koritaanka Gacanta .4 .2 Maalgelinta shirkadaha liiska 7.2.4.3 Maalgelinta hay'adaha dawladda Codsiyo kala duwan oo habdhiska dareenka iyo daaweynta kansarka
8 Muuqaalka tartanka 8.1 Dulmarka muuqaalka tartanka 8.1.1 Horumarrada muhiimka ah 8.1.2 Hawlaha sharciyeynta iyo sharciga 8.1.3 Isku darka iyo iibsiga
9 Suuqa Caalamiga ah ee xakameynta dawooyinka peptide-ka (iyadoo la raacayo tilmaamaha), mln USD, 2024-2040 9.1 Naqshad Tijaabo Caafimaad oo loogu talagalay Xakamaynta Daawaynta Peptide 9.1.1 Daawaynta Wajiga II ee Suurtogalka ah II) .2.4 Daraasaadka aan kiliiniga ahayn ee BT5528 9.1.3 PN-9439.1.3.1 Horudhac Product 4.2 Nakhshad daraasadeed (Wejiga IIb) 9.1.4.3 Waxtarka, badbaadada iyo xogta dulqaadka (Wejiga IIb) 9.1.5 Rusfertide (PTG-300) 9.1.5.1 Dulmarka alaabta 9.1.5.2 Naqshad daraasadeed (Wejiga II) 9.1.5.3 Xogta dulqaadka (Wejiga IIa) 9.1.6 Suurtogalnimada Wajiga III daawooyinka 9.1.7 Zilukoplan (RA101495) 9.1.7.1 Dulmarka alaabta 9.1.7.2 Naqshad daraasadeed (Wejiga III) 9.1.7.3 Waxtarka, badbaadada iyo xogta dulqaadka Pharmacokinetic iyo pharmacodynamic profile of Zilucoplan (Wejiga I) 9.1.8 Rusfertide (PTG- 300) 9.1.8.1 Dulmarka alaabta 9.1.8.2 Naqshad Daraasad (Wejiga III) 9.1.8.3 Waxtarka, badbaadada iyo dulqaadashada xogta (Wejiga II) dhaqdhaqaaqa horumarinta suuqa caalamiga ah ee dawooyinka peptide xaddidan, USD milyan, 2024-2040 guusha 9.2.2.2 Qiimaha wax soo saarka API (CDMO)
10 Suuqa Caalamiga ah ee dawooyinka leh ficilka peptide xaddidan (nooca peptide nooca), US$ mln, 2024-2040 peptide ku xiran (DRP))
11 Suuqa Caalamiga ah ee dawooyinka peptide-ka xaddidan (waxyaabaha suurtagalka ah), mln USD, 2024-2040 (RA101495) 11.1.2.1 API wax soo saarka (guud ahaan) 11.1.2.2 API baahida saadaasha 2024-2040 11.1.3 Rusfertide.301 (PT-1) .3.1 API Production (Outsourcing) Qiimaha 11.1.4 PN-94311.1.4.1 API Production (Outsourcing) 11.1.4.2 API Demand Saadaasha 2024-2040
Waqtiga boostada: Jul-06-2023